This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A prospective, phase IV, open-label, multi-center ...
Clinical trial

A prospective, phase IV, open-label, multi-center study evaluating changes in bone marrow morphology in adult subjects receiving romiplostim for the treatment of thrombocytopenia associated with immune (idiopathic) thrombocytopenia purpura (ITP)

Read time: 1 mins
Last updated:19th May 2009
The primary objective of this study is to evaluate the incidence of collagen fibrosis as evidenced by trichrome staining at Year 1, Year 2, or Year 3 after initial exposure of romiplostim.
Category Value
Study start date 2009-05-19

View full details